DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large cap ...

QRG Capital Management Inc. grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.6% in the 3rd quarter, ...

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

The most convenient way is via an online investment platform or trading app, although you can also buy shares via an appropriate stockbroker or financial advisor. Provided an investor has the ...

Abbott competitor Dexcom also released a similar device for ... But first, people have to buy the devices. “You’ve got to think about who can afford $89 or $99 a month,” Kawalec said.

Insulet ’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on ...

Dexcom Inc is listed on the NASDAQ as a member of the Healthcare ... On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.50.

In the first of this six-part series, Mark Andrews puts Xpeng’s G6 sports-utility vehicle through the paces, concluding that it is not so much a car that you drive than the car that drives you.